Tislelizumab Plus Cetuximab and Irinotecan in Refractory Microsatellite Stable and RAS Wild-Type Metastatic Colorectal Cancer: a Single-Arm Phase 2 Study
Nature Communications(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Nature Communications(2024)